BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16117803)

  • 1. Normal dermal ferrochelatase activity does not protect human skin from protoporphyrin-induced photosensitivity.
    Elder G
    J Invest Dermatol; 2005 Sep; 125(3):580; author reply 580-1. PubMed ID: 16117803
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic study in a Singaporean patient with erythropoietic protoporphyria.
    Chuah SY; Tee SI; Pramono ZA; Theng CT
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):269-71. PubMed ID: 22971195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin ferrochelatase and photosensitivity in mice and man.
    Wahlin S; Harper P
    J Invest Dermatol; 2010 Feb; 130(2):631-3. PubMed ID: 19657351
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy.
    Pawliuk R; Bachelot T; Wise RJ; Mathews-Roth MM; Leboulch P
    Nat Med; 1999 Jul; 5(7):768-73. PubMed ID: 10395321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
    Holme SA; Worwood M; Anstey AV; Elder GH; Badminton MN
    Blood; 2007 Dec; 110(12):4108-10. PubMed ID: 17804693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells.
    Goodwin RG; Kell WJ; Laidler P; Long CC; Whatley SD; McKinley M; Badminton MN; Burnett AK; Williams GT; Elder GH
    Blood; 2006 Jan; 107(1):60-2. PubMed ID: 16150949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
    Leaf RK; Dickey AK
    Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Suzuki H; Kikuchi K; Fukuhara N; Nakano H; Aiba S
    J Dermatol; 2017 Jun; 44(6):651-655. PubMed ID: 28026050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of fecal fat excretion and the disposal of protoporphyrin in a murine model for erythropoietic protoporphyria.
    Gooijert KE; Havinga R; Oosterloo-Duinkerken AR; Venekamp-Hoolsema EE; Kuipers F; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G510-6. PubMed ID: 17600043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics.
    Wahlin S; Floderus Y; Stål P; Harper P
    J Intern Med; 2011 Mar; 269(3):278-88. PubMed ID: 20412370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria.
    Teramura T; Mizuno M; Asano H; Naru E; Kawara S; Kamide R; Kawada A
    J Dermatol; 2018 Feb; 45(2):145-149. PubMed ID: 29266358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homozygote erythropoietic protoporphyria associated with porokeratosis].
    Philippot V; Bérard F; Perrot H
    Ann Dermatol Venereol; 1996; 123(6-7):382-6. PubMed ID: 8959061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature.
    Pagano MB; Hobbs W; Linenberger M; Delaney M
    J Clin Apher; 2012; 27(6):336-41. PubMed ID: 22997063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietic protoporphyria patients in Slovenia.
    Marko PB; Miljković J; Gorenjak M; Povalej P; Kansky A
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Sep; 16(3):99-102, 104. PubMed ID: 17994169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.
    Tutois S; Montagutelli X; Da Silva V; Jouault H; Rouyer-Fessard P; Leroy-Viard K; Guénet JL; Nordmann Y; Beuzard Y; Deybach JC
    J Clin Invest; 1991 Nov; 88(5):1730-6. PubMed ID: 1939658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietic protoporphyria: spectrum of three cases.
    Bertrand J; Clarke JT; Hanna D
    J Cutan Med Surg; 2012; 16(5):311-6. PubMed ID: 22971305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
    Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
    Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low expression allele (IVS3-48C) of the ferrochelatase gene leads to low enzyme activity associated with erythropoietic protoporphyria.
    Tahara T; Yamamoto M; Akagi R; Harigae H; Taketani S
    Int J Hematol; 2010 Dec; 92(5):769-71. PubMed ID: 21132468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.